These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17655657)

  • 21. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
    Nickel JC; Fradet Y; Boake RC; Pommerville PJ; Perreault JP; Afridi SK; Elhilali MM
    CMAJ; 1996 Nov; 155(9):1251-9. PubMed ID: 8911291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial.
    Goldstein I; Fisher WA; Sand M; Rosen RC; Mollen M; Brock G; Karlin G; Pommerville P; Bangerter K; Bandel TJ; Derogatis LR;
    J Sex Med; 2005 Nov; 2(6):819-32. PubMed ID: 16422806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients.
    Wilton L; Pearce G; Edet E; Freemantle S; Stephens MD; Mann RD
    Br J Urol; 1996 Sep; 78(3):379-84. PubMed ID: 8881946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of sexual function in men with benign prostatic hyperplasia by pharmacologic therapy.
    Stojanović N; Bogdanović D
    Srp Arh Celok Lek; 2014; 142(9-10):572-8. PubMed ID: 25518536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
    Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
    N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraprostatic botulinum toxin type A administration: evaluation of the effects on sexual function.
    Silva J; Pinto R; Carvalho T; Botelho F; Silva P; Silva C; Cruz F; Dinis P
    BJU Int; 2011 Jun; 107(12):1950-4. PubMed ID: 21105985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness.
    Motofei IG; Rowland DL; Georgescu SR; Baconi DL; Dimcevici NP; Paunica S; Constantin VD; Balalau C
    BJU Int; 2013 Apr; 111(4 Pt B):E221-6. PubMed ID: 23157321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting.
    Mamoulakis C; Skolarikos A; Schulze M; Scoffone CM; Rassweiler JJ; Alivizatos G; Scarpa RM; de la Rosette JJ
    BJU Int; 2013 Jul; 112(1):109-20. PubMed ID: 23490008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic drug therapy and sexual dysfunction in men.
    Mitchell JE; Popkin MK
    Am J Psychiatry; 1982 May; 139(5):633-7. PubMed ID: 6122381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
    Lowe FC; McConnell JD; Hudson PB; Romas NA; Boake R; Lieber M; Elhilali M; Geller J; Imperto-McGinely J; Andriole GL; Bruskewitz RC; Walsh PC; Bartsch G; Nacey JN; Shah S; Pappas F; Ko A; Cook T; Stoner E; Waldstreicher J;
    Urology; 2003 Apr; 61(4):791-6. PubMed ID: 12670567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.
    Stoner E
    Arch Intern Med; 1994 Jan; 154(1):83-8. PubMed ID: 7505563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Shelbaia A; Elsaied WM; Elghamrawy H; Abdullah A; Salaheldin M
    Urology; 2013 Jul; 82(1):130-5. PubMed ID: 23711438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of medical treatments for benign prostatic hyperplasia on sexual function.
    Giuliano F
    BJU Int; 2006 Apr; 97 Suppl 2():34-8; discussion 44-5. PubMed ID: 16507052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life.
    Carbone DJ; Hodges S
    Int J Impot Res; 2003 Aug; 15(4):299-306. PubMed ID: 12934061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
    Perez-Mora N; Velasco C; Bermüdez F
    Skinmed; 2015; 13(3):179-83. PubMed ID: 26380503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
    Corona G; Rastrelli G; Maseroli E; Balercia G; Sforza A; Forti G; Mannucci E; Maggi M
    J Endocrinol Invest; 2012 Nov; 35(10):915-20. PubMed ID: 22777612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Illicit Use of Amphetamine on Male Sexual Functions.
    Chou NH; Huang YJ; Jiann BP
    J Sex Med; 2015 Aug; 12(8):1694-702. PubMed ID: 26147855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.